HIV Drug Resistance

Infectious Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
HIV Drug resistance testingN/A1 trial
Active Trials
NCT03557021Unknown1,250Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Mission TherapeuticsHIV Drug resistance testing

Clinical Trials (1)

Total enrollment: 1,250 patients across 1 trials

NCT03557021Mission TherapeuticsHIV Drug resistance testing

Impact of HIV Drug Resistance Testing, and Subsequent Change to an Individualized Therapy in Tanzania

Start: Jul 2017Est. completion: Sep 20201,250 patients
N/AUnknown

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space